NCT03516994: Reducing Disparities in the Quality of Advance Care Planning for Older Adults

NCT03516994
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Enrolling by invitation
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 65 Years and older (Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients under 65 years of age; Patients that are residents of a nursing home or assisted living facility
https://ClinicalTrials.gov/show/NCT03516994

Comments are closed.

Up ↑